Pressreleases

SCHOTT Introduces new Pharmaceutical Vials with Minimized Delamination Risk

SCHOTT Vials DC: Innovation based on optimized manufacturing technique and patented SCHOTT Delamination Quicktest / Threshold values for delamination can be set for the first time ever

SHL to Inspire Innovation at the 2013 PDA Conference in Basel, Switzerland

The global injectable drug delivery technologies market is estimated to reach $43bn USD by 2017, much of which is based on drivers like as the surge of biologics and biosimilars and the continuous need to improve patient compliance.

COPA-DATA Launches the new Version of its Reporting Software zenon Analyzer

The software allows current and historical data concerning plant production and energy to be analysed and the results presented in clear, graphical reports. zenon Analyzer 2.10 promises easy integration, more flexibility and ISO 50001 compliance.

Fujifilm Diosynth Biotechnologies’ UK Site Receives Renewed MHRA Manufacturing Licence

Fujifilm Diosynth Biotechnologies has announced that it has received a renewal of its Manufacturer’s Licence from the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). The licence authorises commercial manufacturing at the company’s Billingham, UK site, and was received with zero critical or major observations.

SHL reaches a new milestone of 2000 employees in Taiwan

SHL, the world’s largest privately-owned designer, developer and manufacturer of advanced drug delivery devices, officially announced reaching a new milestone of 2,000 employees in Taiwan as of September 1st 2013.

Mimetix® 3D Plate Awarded ELRIG New Technology Prize

The Electrospinning Company’s multiwell plate for 3D cell culture containing the Mimetix® scaffold was awarded the prize for best new innovative technology at the European Laboratory Robotics Interest Group (ELRIG) Drug Discovery Conference in Manchester in September.

Towards the Reality of Large Scale Production of Human Stem Cells

The Electrospinning Company is a member of the HESUB consortium, which has been awarded €5.7 million over three years by the European Union 7th framework programme to develop a single-use bioreactor for the cost-effective production of human stem cells. The project started on 1 May 2013.

COPA-DATA at SPS IPC Drives Germany 2013

In focus: Ergonomics, mobile solutions and energy management with Zenon.

BIOLATAM, the New Meeting Point for Biotechnology in Latin America Will Host First Edition in Bogota

This year, Bogota will host the first edition of BIOLATAM, on December 9th and 10th. This event will be held biannually, on odd years, and seeks to become the leading event in Latin America for the biotechnology sector and the promotion of business opportunities between bio-technology companies and user sectors (pharmaceutical, food, veterinarian, energy, etc.) from all over the world, whose specific interests are pointed towards Latin America.